The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study
Open accessAbstract
OBJECTIVE: To assess the thrombotic risk associated with oral contraceptive use with a focus on dose of oestrogen and type of progestogen of oral contraceptives available in the Netherlands. DESIGN: Population based case-control study. SETTING: Six participating anticoagulation clinics in the Netherlands (Amersfoort, Amsterdam, The Hague, Leiden, Rotterdam, and Utrecht). PARTICIPANTS: Premenopausal women <50 years old who were not pregnant, not within four weeks postpartum, and not using a hormone excreting intrauterine device or depot contraceptive. Analysis included 1524 patients and 1760 controls. MAIN OUTCOME MEASURES: First objectively diagnosed episodes of deep venous thrombosis of the leg or pulmonary embolism. Odds ratios calculated by cross-tabulation with a 95% confidence interval according to Woolf's method; adjusted odds ratios estimated by unconditional logistic regression, standard errors derived from the model. RESULTS: Currently available oral contraceptives increased the risk of venous thrombosis fivefold compared with non-use (odds ratio 5.0, 95% CI 4.2 to 5.8). The risk clearly differed by type of progestogen and dose of oestrogen. The use of oral contraceptives containing levonorgestrel was associated with an almost fourfold increased risk of venous thrombosis (odds ratio 3.6, 2.9 to 4.6) relative to non-users, whereas the risk of venous thrombosis compared with non-use was increased 5.6-fold for gestodene (5.6, 3.7 to 8.4), 7.3-fold for desogestrel (7.3, 5.3 to 10.0), 6.8-fold for cyproterone acetate (6.8, 4.7 to 10.0), and 6.3-fold for drospirenone (6.3, 2.9 to 13.7). The risk of venous thrombosis was positively associated with oestrogen dose. We confirmed a high risk of venous thrombosis during the first months of oral contraceptive use irrespective of the type of oral contraceptives. CONCLUSIONS: Currently available oral contraceptives still have a major impact on thrombosis occurrence and many women do not use the safest brands with regard to risk of venous thrombosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Incidence and mortality of venous thrombosis: a population‐based study
NÆSS, I. A., CHRISTIANSEN, S. C., ROMUNDSTAD, P., CANNEGIETER, S. C., ROSENDAAL, F. R., & HAMMERSTRØM, J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02450.x · Cited by 1,413
Self-citationVandenbroucke, J. P., Koster, T., Rosendaal, F. R., Briët, E., Reitsma, P. H., & Bertina, R. M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90286-0 · Cited by 1,063
Self-citationJick, H., Jick, S. S., Myers, M. W., Vasilakis, C., & Gurewich, V (1995) · The Lancet · doi:10.1016/s0140-6736(95)91928-7 · Cited by 726
Bloemenkamp, K. W. M., Helmerhorst, F. M., Rosendaal, F. R., Vandenbroucke, J. P., & Büller, H. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91929-5 · Cited by 580
Self-citationDinger, J. C., Heinemann, L. A. J., & Kühl-Habich, D. (2007) · Contraception · doi:10.1016/j.contraception.2006.12.019 · Cited by 470
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis
Kemmeren, J. M., Algra, A., & Grobbee, D. E. (2001) · BMJ · doi:10.1136/bmj.323.7305.131 · Cited by 455
Poulter, N. R., Cl, C., Farley, T., Meirik, O., & Marmot, M. G. (1995) · PubMed · Cited by 404
Oral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic Disease
Gerstman, B. B., Piper, J. M., Tomita, D. K., Ferguson, W. J., Stadel, B. V., & Lundin, F. E. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115799 · Cited by 352
Oral contraceptives and venous thromboembolism: a five-year national case-control study☆
Lidegaard, Ø., Edström, B., & Kreiner, S. (2002) · Contraception · doi:10.1016/s0010-7824(01)00307-9 · Cited by 334
Population-based study of risk of venous thromboembolism associated with various oral contraceptives
Farmer, R., Lawrenson, R., Thompson, C., Kennedy, J., & Hambleton, I. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07496-x · Cited by 329
Farley, T., Meirik, O., Cl, C., Marmot, M. G., & Poulter, N. R. (1995) · PubMed · Cited by 319
Combined oral contraceptive pills for treatment of acne
Arowojolu, A. O., Gallo, M. F., Lopez, L. M., & Grimes, D. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004425.pub6 · Cited by 308
Combination contraceptives: effects on weight
Gallo, M. F., Lopez, L. M., Grimes, D. A., Carayon, F., Schulz, K. F., & Helmerhorst, F. M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003987.pub5 · Cited by 290
Self-citationOral contraceptives containing drospirenone for premenstrual syndrome
Lopez, L. M., Kaptein, A. A., & Helmerhorst, F. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006586.pub4 · Cited by 270
Self-citationOral contraceptives and venous thromboembolism: findings in a large prospective study.
Vessey, M., Mant, D., Smith, A., & Yeates, D. (1986) · BMJ · doi:10.1136/bmj.292.6519.526 · Cited by 259
(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)89711-6 · Cited by 259
Oelkers, W. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.6.1816 · Cited by 246
Meijers, J., van den Ende, A., van Enk, A., Bouma, B., Tans, G., Rosing, J., Prins, M., Büller, H., & Middeldorp, S. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613958 · Cited by 217
Tans, G., Curvers, J., Middeldorp, S., Thomassen, M. C., Prins, M., Bouma, B., Büller, H., Meijers, J., & Rosing, J. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613960 · Cited by 203
Combination contraceptives: effects on weight
Gallo, M. F., Lopez, L. M., Grimes, D. A., Schulz, K. F., & Helmerhorst, F. M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003987.pub3 · Cited by 196
Self-citationOral contraceptives and venous thromboembolism
Lidegaard, Ø., Edström, B., & Kreiner, S. (1998) · Contraception · doi:10.1016/s0010-7824(98)00033-x · Cited by 186
Drospirenone: a Novel Progestogen with Antimineralocorticoid and Antiandrogenic Activity
MUHN, P., FUHRMANN, U., FRITZEMEIER, K. H., KRATTENMACHER, R., & SCHILLINGER, E. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb31386.x · Cited by 185
van Vloten, W. A., van Haselen, C. W., van Zuuren, E. J., Gerlinger, C., & Heithecker, R. (2002) · PubMed · Cited by 173
Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives
Vasilakis-Scaramozza, C., & Jick, H. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06522-9 · Cited by 160
Risk of Thromboembolism in Women Taking Ethinylestradiol/Drospirenone and Other Oral Contraceptives
Seeger, J. D., Loughlin, J., Eng, P. M., Clifford, C. R., Cutone, J., & Walker, A. M. (2007) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000279448.62221.a8 · Cited by 158
Tans, G., Vlieg, A. V. H., Thomassen, S., Curvers, J., Bertina, R. M., Rosing, J., & Rosendaal, F. R. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04443.x · Cited by 150
Self-citationOld and new risk factors for upper extremity deep venous thrombosis
Blom, J. W., Doggen, C. J. M., Osanto, S., & Rosendaal, F. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01625.x · Cited by 147
Self-citationBloemenkamp, K. W. M., Rosendaal, F. R., Buller, H. R., Helmerhorst, F. M., Colly, L. P., & Vandenbroucke, J. P. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.1.65 · Cited by 141
Self-citationDrospirenone: A novel progestogen with antimineralocorticoid and antiandrogenic activity
Muhn, P., Krattenmacher, R., Beier, S., Elger, W. A. G., & Schillinger, E. (1995) · Contraception · doi:10.1016/0010-7824(94)00015-o · Cited by 128
Newer Oral Contraceptives and the Risk of Venous Thromboembolism
Walker, A. M. (1998) · Contraception · doi:10.1016/s0010-7824(98)00014-6 · Cited by 104
Oral contraceptives and fatal pulmonary embolism
Parkin, L., Skegg, D. C. G., Wilson, M., Herbison, P., & Paul, C. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02382-5 · Cited by 100
van Vliet, H. A. A. M., Frölich, M., Thomassen, S., Thomassen, S., Doggen, C. J. M., Rosendaal, F. R., Rosing, J., & Helmerhorst, F. M. (2004) · Human Reproduction · doi:10.1093/humrep/deh612 · Cited by 92
Self-citationRisk Factors for Fatal Venous Thromboembolism in Young Women: A Case-Control Study
Thorogood, M., Mann, J. I., Murphy, M. S., & Vessey, M. P. (1992) · International Journal of Epidemiology · doi:10.1093/ije/21.1.48 · Cited by 90
Combination contraceptives: effects on weight
Gallo, M. F., Lopez, L. M., Grimes, D. A., Schulz, K. F., & Helmerhorst, F. M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003987.pub2 · Cited by 80
Self-citationFarley, T. (1999) · Human Reproduction Update · doi:10.1093/humupd/5.6.721 · Cited by 77
Vandenbroucke, J. P., Helmerhorst, F. M., Bloemenkamp, K. W. M., & Rosendaal, F. R. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70289-8 · Cited by 73
Self-citationKemmeren, J. M., Meijers, J. C. M., Bouma, B. N., Grobbee, D. E., & Algra, A. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612973 · Cited by 67
Oral contraceptives containing drospirenone for premenstrual syndrome
Lopez, L. M., Kaptein, A. A., & Helmerhorst, F. M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006586.pub2 · Cited by 57
Self-citationCardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group.
(1998) · PubMed · Cited by 57
(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)89714-1 · Cited by 50
Combined oral contraceptive pills for treatment of acne
Arowojolu, A. O., Gallo, M. F., Lopez, L. M., Grimes, D. A., & Garner, S. E. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004425.pub3 · Cited by 48
van Vliet, H. A. A. M., Winkel, T. A., Noort, I. V. D. H., Rosing, J., & Rosendaal, F. R. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00983.x · Cited by 47
Self-citationFluorouracil and folinic acid in colon cancer
Hughes‐Davies, L., Rescigno, J., & Marsoni, S. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91136-7 · Cited by 45
Seaman, H. E., de Vries, C. S., & Farmer, R. D. T. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.896 · Cited by 41
Dutch GPs warned against new contraceptive pill
Sheldon, T. (2002) · BMJ · doi:10.1136/bmj.324.7342.869 · Cited by 37
Kuhnz, W., Stairs, T., & Jütting, G. (1993) · Contraception · doi:10.1016/0010-7824(93)90118-q · Cited by 34
THE DEVELOPMENT AND EVALUATION OF AN OVULATION INHIBITOR (DIANE®) CONTAINING AN ANTIANDROGEN
Lachnit-Fixson, U. (1979) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016347909157227 · Cited by 34
Risk of Thromboembolism in Women Taking Ethinylestradiol/Drospirenone and Other Oral Contraceptives
Mendenhall, M. (2008) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2007.11.018 · Cited by 9
Cited by
Lidegaard, O., Nielsen, L. H., Skovlund, C. W., Skjeldestad, F. E., & Lokkegaard, E. (2011) · BMJ · doi:10.1136/bmj.d6423 · Cited by 608
Thrombotic stroke and myocardial infarction with hormonal contraception
Lidegaard, Ø., Løkkegaard, E., Jensen, A., Skovlund, C. W., & Keiding, N. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1111840 · Cited by 607
Escobar-Morreale, H. F., Carmina, E., Dewailly, D., Gambineri, A., Kelestimur, F., Moghetti, P., Pugeat, M., Qiao, J., Wijeyaratne, C. N., Witchel, S. F., et al. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr042 · Cited by 494
Stegeman, B. H., de Bastos, M., Rosendaal, F. R., van Hylckama Vlieg, A., Helmerhorst, F. M., Stijnen, T., & Dekkers, O. M. (2013) · BMJ · doi:10.1136/bmj.f5298 · Cited by 420
Self-citationOtt, M. A., Sucato, G. S., COMMITTEE ON ADOLESCENCE, Braverman, P. K., Adelman, W. P., Alderman, E. M., Breuner, C. C., Levine, D. A., Marcell, A. V., & O’Brien, R. F. (2014) · PEDIATRICS · doi:10.1542/peds.2014-2300 · Cited by 402
Metadata
- Authors
- van Hylckama Vlieg, A., Helmerhorst, F. M., Vandenbroucke, J. P., Doggen, C. J. M., & Rosendaal, F. R.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2009-08-13
- Volume
- 339
- Issue
- aug13 2
- Pages
- b2921-b2921
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2137955943
- Cited by
- 666
- References
- 48
- FWCI
- 40.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.